| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.24B | -8.0% |
| Cost of Revenue | $1.75B | -13.4% |
| Gross Profit | $1.49B | -0.7% |
| R&D Expense | $316.1M | +14.0% |
| SG&A Expense | $446.6M | -22.5% |
| Operating Income | $533.9M | +7.0% |
| Interest Expense | $215.2M | -31.1% |
| Pre-tax Income | $322.1M | +86.5% |
| Income Tax | $28.3M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $329.2M | -28.0% |
| Inventory | $638.1M | +5.1% |
| Current Assets | $1.62B | -18.3% |
| Total Assets | $8.39B | -4.7% |
| Current Liabilities | $525.2M | +2.2% |
| Long-term Debt | $3.98B | -13.0% |
| Stockholders' Equity | $3.69B | +8.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $631.7M | +0.3% |
| Capital Expenditures | $315.6M | -30.9% |
| Investing Cash Flow | -$67.1M | -112.1% |
| Financing Cash Flow | -$689.0M | +46.3% |
| Free Cash Flow | $316.1M | +83.0% |
| +436.8% |
| Net Income | $292.8M | +62.1% |
| EPS (Basic) | $1.94 | +60.3% |
| EPS (Diluted) | $1.93 | +60.8% |